Elevar Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Elevar Therapeutics

Access the complete profile.

Elevar Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	2755 E Cottonwood Pkwy Ste 540 Salt Lake City, UT 84121

Note: Revenues for privately held companies are statistical evaluations.


Elevar Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Elevar Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Elevar Therapeutics is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Elevar Therapeutics Annual Revenue and Growth Rate

Elevar Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Elevar Therapeutics's revenues are gauged from an analysis of company filings.

Elevar Therapeutics's Income Statement (based on Industry Averages)

Elevar Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Elevar Therapeutics is developing and marketing. Elevar Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ELEVAR CARE CONNECT Providing financial assistance for prescription costs; Providing information about healthcare insurance plans; Providing counseling and consulting in the field of healthcare insurance benefits; Providing healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claim processing support, and claims appeal support	01/18/2024
TULVEGIO RIVOCERANIB Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer	09/17/2019

See all trademarks and details in the Full Report.

Market Share of Elevar Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Elevar Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Elevar Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
USANA HEALTH SCIENCES	Salt Lake City, UT	100
NUTRACEUTICAL	Salt Lake City, UT	56
JOLLEYS COMPOUNDING PHARMACY	Salt Lake City, UT	14
VMN	Murray, UT	3
TSN ASSET MANAGEMENT	Salt Lake City, UT	2
ELEVAR THERAPEUTICS	Salt Lake City, UT	2

Future Competition: Elevar Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Elevar Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)